Navigation Links
Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment
Date:12/1/2009

Primary Data and Information Gathering 133

Secondary data and information gathering 134

Definitions of Product-Life Cycle stages 136

Glossary of abbreviations and acronyms 137

List of Figures

Figure 1.1: Key issues facing Pharma and Biotech companies 16

Figure 1.2: Cost of bringing a drug to market ($m), 1975-2008 21

Figure 1.3: Pharmaceutical R&D expenditure ($bn), 2004-2009e 22

Figure 1.4: Biotechnology R&D expenditure ($bn), 2004-2009e 22

Figure 1.5: Cost of clinical trials in the US ($bn), 2005-2011e 23

Figure 2.6: Comparison of locations across selected countries 38

Figure 2.7: Korean Food and Drug Administration (KFDA) Approval Process 43

Figure 2.8: CRO Segment Leaders 45

Figure 2.9: Enhanced clinical site effectiveness (patients per site) in the emerging countries 48

Figure 2.10: Fewer ineffective sites in the emerging countries 48

Figure 2.11: Critical components for capacity building/conducting clinical trials 54

Figure 2.12: Assessing clinical trial location feasibility 55

Figure 2.13: CRO selection criteria 70

Figure 3.14: Pharmaceutical market by selected Central and Eastern European countries, 2007 84

Figure 3.15: Clinical trials Europe 90

Figure 3.16: Clinical trials by phase (no trials) in the Czech Republic, 2008 91

Figure 3.17: Clinical trials market ($m) in Poland, 2007-2010 92

Figure 3.18: Clinical trials by therapy area (%) in Russia, 2008 93

Figure 3.19: Clinical trials by phase (%) in Russia, 2008 94

Figure 3.20: FDA inspection deficiencies in Russian sites 101

List of Tables

Table 2.1: Demographics of selected emerging markets, 2007 40

Table 2.2: Ethical principles & their application for research 62

Table 3
'/>"/>

SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013
2. Reportlinker Adds Biotechnology Reagents - A Global Market Perspective
3. Reportlinker Adds Bioinformatics - A Global Market Intelligence Report
4. Reportlinker Adds Diclofenac sodium (CAS 15307-79-6) Market Research Report 2009
5. Reportlinker Adds World Bioplastics Industry
6. Reportlinker Adds Cancer Vaccines: Measuring Market Potential
7. Reportlinker Adds Molecular Diagnostics: A Dynamic and Rapidly Broadening Market
8. Reportlinker Adds Worldwide Optical, Transmission TEM, and Scanning SEM Electron Microscope Market Shares, Strategies, and Forecasts, 2009 to 2015
9. Reportlinker Adds Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment
10. Reportlinker Adds Bioinformatics and Computational Biology: Bottlenecks and Options
11. Reportlinker Adds Global Top 10 Biotechnology Companies -- Industry, Financial and SWOT Analysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015 Imagine ... feelings - and those of others. Being able to ... Analyze and read people to anticipate their thoughts and ... deepest emotions and feelings to create unique abstract paintings ... responsive games. Get inside a first-person-shooter as it creates ...
(Date:5/21/2015)... 21, 2015  CytRx Corporation (NASDAQ: CYTR ... in oncology, today announced positive updated results from ... for the treatment of unresectable glioblastoma multiforme (GBM), ... multisite trial is designed to investigate the preliminary ... tumors have progressed following prior treatment with surgery, ...
(Date:5/21/2015)... 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (TSX.V: ... company focused on the development of autologous cell ... the International Society for Cellular Therapy (ISCT) on ... currently in a Phase 1/2 clinical trial.  The ... from 5:30 PM to 7:00 PM local time, ...
(Date:5/20/2015)... SAN FRANCISCO, Calif. , May 20, 2015 ... VCYT ) today presented preliminary data demonstrating the ... distinguish idiopathic pulmonary fibrosis (IPF) from other interstitial ... The findings suggest the classifier,s potential to help ... surgery to resolve ambiguity in IPF diagnosis – ...
Breaking Biology Technology:5 Days to Meet ARGUS - The World's First Contactless Emotions Scanner 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 4Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 5
... Sept. 18 Pharmasset, Inc.,(Nasdaq: VRUS ) announced ... Global Life Sciences Conference being held from September 24 ... Pharmasset,s President & Chief,Executive Officer, will provide an overview ... AM (ET). To access a simultaneous webcast of ...
... Calif., Sept. 18 Dynavax,Technologies Corporation (Nasdaq: ... Chief Financial Officer, will present an overview of ... Conference in New York, New,York on Tuesday, September ... a.m. PDST). The presentation will be webcast. ...
... Survival Advantage of ... Cells after HIV Infection, RICHMOND, Calif., Sept. 18 ... today the presentation of data,demonstrating that human CD4 T-cells ... with zinc finger DNA-binding protein nucleases,(ZFN(TM)) and preferentially survive ...
Cached Biology Technology:Pharmasset to Present at the UBS Global Life Sciences Conference on Monday, September 24th 2Dynavax to Present at UBS 2007 Global Life Sciences Conference 2Sangamo BioSciences Presents Data Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic 2Sangamo BioSciences Presents Data Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic 3Sangamo BioSciences Presents Data Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic 4Sangamo BioSciences Presents Data Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic 5
(Date:4/27/2015)... , Apr. 27, 2015 Profile Solutions, Inc. ... and security systems is pleased to announce that Dr ... a consultant and member of its scientific advisory board. ... known as a thought leader in technology-enhanced learning models. ... Group, and has published studies and books focused on ...
(Date:4/20/2015)... 2015 The announcement comes as ... Records Management (GRM), Ireland,s foremost records ... Having built up an impressive track record of clients within ... within the records management sector in Dubai ... GCC staffbase and employ a further eight staff members at ...
(Date:4/14/2015)... Conn. , April 14, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... been nominated for the 2015 New York Design Awards ... The Design100, New York City Design Awards are part ... based on over 2,500 ratings from the marketplace, industry ...
Breaking Biology News(10 mins):Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3
... "In the DNA of living beings, we have identified ... a certain species, differ among the various species," explained Prof. ... Plants at the University of Bonn. "Based on these markers, ... result of this analysis resembles a barcode at the supermarket; ...
... ALERT , "Basic science and clinical medicine move at ... at improving strategies to manage cancer patients. We need to ... implement them in the clinic." Sherene Loi and ... focus on four major areas: , Molecular pathology, ...
... Heart Foundation (BHF), has tested a new imaging method which ... having a heart attack (1). Scientists from the ... collaboration with the University of Cambridge are the first to ... image the disease processes directly in the coronary arteries that ...
Cached Biology News:Genetic markers for tracking species 2Fourth IMPAKT Breast Cancer Conference 2Fourth IMPAKT Breast Cancer Conference 3Scientists develop new technique that could improve heart attack prediction 2
... Transcriptase (AMV RT) catalyzes the polymerization of ... hybrids (1). It requires a primer (DNA ... as well as Mg2+ or Mn2+. The ... Both nonionic detergents and sulfhydryl compounds stabilize ...
Request Info...
...
Request Info...
Biology Products: